Clinical and laboratory evaluation of rewarming and bed bath of septic patients with hypothermia

Not Applicable

Recruiting

• Conditions: Hypothermia; C23.550.470.790.500

• Registration Number: RBR-3wyt73p
• Lead Sponsor: Programa de Pós-Graduação em Ciências Cardiovasculares - Universidade Federal Fluminense

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-12-11
• Last Update Posted: 29 May 2023
• Study Completion: 2024-04-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients over 18 years old; admitted to the Intensive Care Unit; diagnosed with sepsis according to the criteria known as Sepsis 3; with a suspected or documented infection; with a sharp increase 2 in the SOFA index.

Exclusion Criteria

Extensive burns (greater than 30% of the body surface); metastatic cancer; cerebral tumor; head trauma; spinal cord injury; pregnancy; use of active cooling less than 24 hours of sepsis diagnosis; surgery less than 24 hours after the first occurrence of hypothermia.
For thermography analyzes, patients who do not tolerate exposure to room temperature (temperature of 23 more or less 1ºC for 15 minutes) required for thermalization.
For the analysis of the impact of different types of baths on the bed, the following will also be excluded:
Individuals with continuous infusion of regular insulin at the time of bed bath, due to reduced
glycemia caused by the medication; Patients on hemodialysis (HD) when bathing in bed, due to the reduction in blood glucose caused by the procedure; Patients diagnosed with tumors that affect insulin production, due to the inability to
define whether the cause of eventual glycemic changes is the bed bath or the activity of the tumor; Patients who resent hypoglycemia (blood glucose lower than 70mg / dl) in the pre-bath moment, in addition to to control a possible confounder, avoid the occurrence of severe hypoglycemia (less than 40 mg / dL); Patients in palliative care for any pathology, because the therapeutic proposal for palliation is not consistent with curative actions.

Study & Design

• Study Type: Intervention
• Study Design: Not specified